These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 24983717
1. Pharmacokinetics of atazanavir/ritonavir among HIV-infected Thai children concomitantly taking tenofovir disoproxil fumarate. Bunupuradah T, Techasaensiri C, Keadpudsa S, Thammajaruk N, Srimuan A, Sahakijpicharn T, Prasitsuebsai W, Ananworanich J, Puthanakit T, HIV-NAT 146 Study Team. Pediatr Infect Dis J; 2014 Dec; 33(12):e316-9. PubMed ID: 24983717 [Abstract] [Full Text] [Related]
7. Atazanavir pharmacokinetics with and without tenofovir during pregnancy. Mirochnick M, Best BM, Stek AM, Capparelli EV, Hu C, Burchett SK, Rossi SS, Hawkins E, Basar M, Smith E, Read JS, IMPAACT 1026s Study Team. J Acquir Immune Defic Syndr; 2011 Apr 15; 56(5):412-9. PubMed ID: 21283017 [Abstract] [Full Text] [Related]
11. Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures. Johnson M, Grinsztejn B, Rodriguez C, Coco J, DeJesus E, Lazzarin A, Lichtenstein K, Rightmire A, Sankoh S, Wilber R. AIDS; 2005 Apr 29; 19(7):685-94. PubMed ID: 15821394 [Abstract] [Full Text] [Related]
12. Beneficial pharmacokinetic interaction between atazanavir and lopinavir/ritonavir. Pham PA, Flexner C, Parsons T, Vasist L, Fuchs E, Carson K, Agarwala S, Barditch-Crovo P. J Acquir Immune Defic Syndr; 2007 Jun 01; 45(2):201-5. PubMed ID: 17414932 [Abstract] [Full Text] [Related]
15. Evaluation of efficacy, safety, pharmacokinetics, and adherence in HIV-1-infected, antiretroviral-naïve patients treated with ritonavir-boosted atazanavir plus fixed-dose tenofovir DF/emtricitabine given once daily. Elion R, Cohen C, Ward D, Ruane P, Ortiz R, Reddy YS, Ebrahimi R, McColl D, Kearney B, Fisher A, Flaherty J, BATON Study Group. HIV Clin Trials; 2008 Jun 01; 9(4):213-24. PubMed ID: 18753116 [Abstract] [Full Text] [Related]
16. Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients. Bonora S, Gonzalez de Requena D, D'Avolio A, Calcagno A, Tettoni M, Siccardi M, Baietto L, Simiele M, Trentini L, Di Perri G. Antivir Ther; 2011 Jun 01; 16(4):499-504. PubMed ID: 21685537 [Abstract] [Full Text] [Related]
19. Abacavir/lamivudine versus tenofovir/emtricitabine with atazanavir/ritonavir for treatment-naive Japanese patients with HIV-1 infection: a randomized multicenter trial. Nishijima T, Takano M, Ishisaka M, Komatsu H, Gatanaga H, Kikuchi Y, Endo T, Horiba M, Kaneda S, Uchiumi H, Koibuchi T, Naito T, Yoshida M, Tachikawa N, Ueda M, Yokomaku Y, Fujii T, Higasa S, Takada K, Yamamoto M, Matsushita S, Tateyama M, Tanabe Y, Mitsuya H, Oka S, Epzicom-Truvada study team. Intern Med; 2013 Jun 01; 52(7):735-44. PubMed ID: 23545667 [Abstract] [Full Text] [Related]